J. Lorrain

发表

Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchanger

C. Hoornaert, P. Janiak, J. Lorrain, 2000, British journal of pharmacology.

JPET # 59873 1 Effects of SanOrg 123781 A , a synthetic heparin mimetic , in a mouse model of electrically induced carotid artery injury : synergism with the antiplatelet agent clopidogrel

N. Roome, J. Herbert, R. Masson, 2003 .

Adrenergic and nonadrenergic cotransmitters inhibit insulin secretion during sympathetic stimulation in dogs.

A. Oblin, S. Z. Langer, J. Lorrain, 1992, The American journal of physiology.

CARDIOVASCULAR CHARACTERIZATION OF THE DA2 DOPAMINE RECEPTOR AGONIST QUINPIROLE IN RATS

F. Lhoste, J. Lechaire, J. Lorrain, 1987, Fundamental & clinical pharmacology.

SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis

J. Herbert, L. Millet, J. Lorrain, 2004, Journal of thrombosis and haemostasis : JTH.

Antithrombotic Properties of SSR182289A, a New, Orally Active Thrombin Inhibitor

J. Herbert, L. Millet, J. Lorrain, 2003, Journal of Pharmacology and Experimental Therapeutics.

Effects of SanOrg123781A, a synthetic heparin mimetic, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel.

J. Herbert, R. Masson, J. Lorrain, 2003 .

SSR182289A, a selective and potent orally active thrombin inhibitor.

J. Herbert, Z. Bocskei, J. Lorrain, 2004, Bioorganic & medicinal chemistry.

Effects of SanOrg123781A, a Synthetic Hexadecasaccharide, in a Mouse Model of Electrically Induced Carotid Artery Injury: Synergism with the Antiplatelet Agent Clopidogrel

N. Roome, J. Herbert, R. Masson, 2004, Journal of Pharmacology and Experimental Therapeutics.

Antiplatelet and Antithrombotic Activity of SL65.0472, a Mixed 5-HT1B/5-HT2A Receptor Antagonist

J. Herbert, P. Savi, P. Janiak, 2001, Thrombosis and Haemostasis.

5-HT4 receptors, present in piglet atria and sensitive to SDZ 205-557, are absent in papillary muscle.

J. Lorrain, A. Grosset, S. O'Connor, 1992, European journal of pharmacology.

Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.

B. Scatton, F. Lhoste, J. Lorrain, 1985, Journal of Pharmacology and Experimental Therapeutics.

Studies on the mechanisms of the development of tolerance to the hypotensive effects of fenoldopam in rats.

J. Lechaire, J. Lorrain, I. Cavero, 1988, Journal of cardiovascular pharmacology.